| Ayla R Priestley, NP | |
|
437 S Main St, Bradford, VT 05033-9196 | |
| (802) 222-9317 | |
| Not Available |
| Full Name | Ayla R Priestley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 437 S Main St, Bradford, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679038806 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 101.0134265 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cottage Hospital | Woodsville, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Central Vermont Medical Center | Barre, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Little Rivers Health Care, Inc. | 8224031497 | 20 |
News Archive
Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
Johns Hopkins researchers looked into the brain scans of persons with mild loss of thought and memory and have found that they have significantly low levels of serotonin in their brains. Serotonin is a natural brain chemical that is responsible for several functions including mood, sleep and appetite and also is important for several mental health conditions.
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute '09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 5 days ago
| Entity Name | Little Rivers Health Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163555 PECOS PAC ID: 8224031497 Enrollment ID: O20061003000417 |
News Archive
Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
Johns Hopkins researchers looked into the brain scans of persons with mild loss of thought and memory and have found that they have significantly low levels of serotonin in their brains. Serotonin is a natural brain chemical that is responsible for several functions including mood, sleep and appetite and also is important for several mental health conditions.
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute '09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ayla R Priestley, NP 538 Upper Pln, Bradford, VT 05033-9006 Ph: (603) 359-2287 | Ayla R Priestley, NP 437 S Main St, Bradford, VT 05033-9196 Ph: (802) 222-9317 |
News Archive
Pfizer Inc. announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a statistically significant positive effect compared to placebo in the primary endpoint, time to loss of therapeutic response (LTR).
Quality of life for disabled elderly people is most closely tied to two factors: a sense of dignity and a sense of control, according to a study by researchers at the San Francisco VA Medical Center (SFVAMC) and the University of California, San Francisco.
Johns Hopkins researchers looked into the brain scans of persons with mild loss of thought and memory and have found that they have significantly low levels of serotonin in their brains. Serotonin is a natural brain chemical that is responsible for several functions including mood, sleep and appetite and also is important for several mental health conditions.
Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute '09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.
Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could-if given early enough-potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection.
› Verified 5 days ago
Nancy Ryan Foote, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Plain Suite 1, Upper Plain, Bradford, VT 05033 Phone: 802-222-4722 Fax: 802-222-4709 | |
Alexandria L Noble, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4722 Fax: 802-222-4709 | |
Renee Boudreau Cather, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4722 | |
Abigail Reiber Henderson, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4722 | |
Mrs. Maureen Boardman, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 437 S Main St, Bradford, VT 05033 Phone: 802-222-5562 Fax: 802-222-9276 | |
Ms. Rachel B Morse, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 437 S Main St, Bradford, VT 05033 Phone: 802-222-9317 Fax: 888-462-0883 |